Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06582030
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-06-27
Brief Title:
Stop Addiction Stigma
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Stop Addiction Stigma Training Workshop With Case Vignettes to Decrease Stigmatizing Attitudes Toward People With Substance Abuse Disorders
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial evaluates the impact of a Stop Addiction Stigma SAS training workshop with a short description of the conditions related to addiction vignettes on stigmatizing attitudes toward individuals with substance abuse disorders Reviews have shown that patients with substance abuse disorders have experienced negative attitudes from their health care providers Negative attitudes may lead to less involvement from the provider and the patient and may lead to less effective care Using case vignettes with a SAS workshop may be an effective method to help people learn about addiction reduce the stigma toward addiction and improve the quality of health care
Detailed Description:
PRIMARY OBJECTIVE
I To describe the impact of SAS training on participants responses to people with a substance impairment
SECONDARY OBJECTIVES
I To evaluate the feasibility of stigma training workshops on stigmatizing attitudes health care personnel
II To explore the maintainability of responses over time III To explore relationships between language and stigmatizing attitudes
OUTLINE Participants are randomized to 1 of 6 group case vignettes
GROUP A CHRONICALLY RELAPSING BRAIN DISEASE Participants view the chronically relapsing brain disease vignette and attend a SAS workshop on study
GROUP B BRAIN DISEASE Participants view the brain disease vignette and attend a SAS workshop on study
GROUP C DISEASE Participants view the disease vignette and attend a SAS workshop on study
GROUP D ILLNESS Participants view the illness vignette and attend a SAS workshop on study
GROUP E DISORDER Participants view the disorder vignette and attend a SAS workshop on study
GROUP F PROBLEM Participants view the problem vignette and attend a SAS workshop on study
I To describe the impact of SAS training on participants responses to people with a substance impairment
SECONDARY OBJECTIVES
I To evaluate the feasibility of stigma training workshops on stigmatizing attitudes health care personnel
II To explore the maintainability of responses over time III To explore relationships between language and stigmatizing attitudes
OUTLINE Participants are randomized to 1 of 6 group case vignettes
GROUP A CHRONICALLY RELAPSING BRAIN DISEASE Participants view the chronically relapsing brain disease vignette and attend a SAS workshop on study
GROUP B BRAIN DISEASE Participants view the brain disease vignette and attend a SAS workshop on study
GROUP C DISEASE Participants view the disease vignette and attend a SAS workshop on study
GROUP D ILLNESS Participants view the illness vignette and attend a SAS workshop on study
GROUP E DISORDER Participants view the disorder vignette and attend a SAS workshop on study
GROUP F PROBLEM Participants view the problem vignette and attend a SAS workshop on study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None